Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 14
1.2 List of Figures 19
2 Introduction 22
2.1 What Is This Report
About? 22
3 Definitions of Markets Covered in the Report 23
3.1
Cardiovascular Devices 23
3.2 Cardiac Rhythm Management 23
3.2.1
Cardiac Resynchronisation Therapy 23
3.2.1.1 Cardiac Resynchronisation
Therapy - Defibrillator 23
3.2.1.2 Cardiac Resynchronisation Therapy -
Pacemaker 23
3.2.2 Cardiovascular Pacing and ICD Leads 23
3.2.3
Implantable Cardioverter Defibrillator 24
3.2.3.1 Dual Chamber Implantable
Cardioverter Defibrillator 24
3.2.3.2 Single Chamber Implantable
Cardioverter Defibrillator 24
3.2.4 Pacemaker 24
3.2.4.1 Dual Chamber
Pacemaker 24
3.2.4.2 Single Chamber Pacemaker 24
3.3 Cardiovascular
Monitoring and Diagnostic Devices 24
3.3.1 ECG Monitoring Equipment 24
3.3.2 ECG Stress Testing Systems 25
3.3.3 Event Monitoring Systems 25
3.3.4 Holter Monitoring Systems 25
3.4 Cardiovascular Prosthetic Devices
25
3.4.1 Cardiac Assist Devices 25
3.4.1.1 Intra-Aortic Balloon Pump
25
3.4.1.2 Intra-Aortic Balloon Pump Catheters 25
3.4.1.3 Total
Artificial Heart 25
3.4.1.4 Ventricular Assist Devices 26
3.4.2
Cardiac Valve Repair 26
3.4.3 Prosthetic Heart Valve 26
3.4.3.1
Mechanical Heart Valve 26
3.4.3.2 Tissue Heart Valve 26
3.5
Cardiovascular Surgery 26
3.5.1 Beating Heart Surgery Systems 26
3.5.2
Cardiac Ablation Devices 26
3.5.3 Cardiopulmonary Bypass Equipment 27
3.5.4 Perfusion Disposables 27
3.5.4.1 Custom Packs 27
3.5.4.2
Oxygenators 27
3.6 Electrophysiology 27
3.6.1 Electrophysiology
Ablation Catheter 27
3.6.2 Electrophysiology Diagnostic Catheter 27
3.6.3 Electrophysiology Lab Systems 28
3.7 Interventional Cardiology
28
3.7.1 Arteriotomy Closure Devices 28
3.7.2 Cardiac Catheter 28
3.7.2.1 Angiography Catheter 28
3.7.2.2 Guiding Catheter 28
3.7.3
Coronary Guidewire 28
3.7.4 Coronary Stent 28
3.7.4.1 Bare Metal Stent
29
3.7.4.2 Drug Eluting Stent (DES) 29
3.7.5 PTCA Balloon 29
3.7.5.1 FW Balloon 29
3.7.5.2 Over the Wire Balloon 29
3.7.5.3 Rx
Balloon 29
3.8 Peripheral Vascular Devices 29
3.8.1 Aortic Stent Graft
29
3.8.2 Embolic Protection Devices 30
3.8.3 Inferior Vena Cava Filter
30
3.8.4 Peripheral Guidewire 30
3.8.5 Peripheral Vascular Stent
30
3.8.6 PTA Balloon 30
3.8.7 Synthetic Surgical Grafts 30
4
Healthcare Sector Review 31
4.1 Healthcare Expenditure 31
4.2
Healthcare Infrastructure 34
4.3 Healthcare Policy 36
4.3.1 Health
Insurance Act 37
4.3.2 Healthcare Allowance Act 37
4.3.3 The
Exceptional Medical Expenses Act 37
5 Regulation System 38
5.1 Medical
Equipment Approval Process 38
5.1.1 Classification of Medical Devices
39
5.1.2 Conformity Assessment Process 48
5.1.2.1 Class I devices
48
5.1.2.2 Class IIa devices 49
5.1.2.3 Class IIb devices 50
5.1.2.4 Class III devices 51
5.2 Post Market Surveillance (PMS) 51
6
Pricing and Reimbursement 52
6.1 Pricing and Reimbursement in Netherlands
52
7 Distribution Structure 53
7.1 Distribution Structure in
Netherlands 53
8 Cardiovascular Devices In Netherlands 54
8.1
Cardiovascular Devices, Netherlands, Overall Revenue ($ mn), 2000-2015 54
8.2 Cardiovascular Devices, Netherlands, Category Volume (Units), 2000-2015
60
8.3 Cardiovascular Devices, Netherlands, Company Share (2007-2008)
65
9 Cardiac Rhythm Management In Netherlands 66
9.1 Cardiac Rhythm
Management Overall Revenue (2000-2015) 66
9.1.1 Cardiac Resynchronisation
Therapy Overall Revenue (2000-2015) 68
9.1.2 Implantable Cardioverter
Defibrillator Overall Revenue (2000-2015) 70
9.1.3 Pacemaker Overall
Revenue (2000-2015) 72
9.2 Cardiac Rhythm Management Overall Volume
(2000-2015) 74
9.2.1 Cardiac Resynchronisation Therapy Overall Volume
(2000-2015) 76
9.2.2 Implantable Cardioverter Defibrillator Overall Volume
(2000-2015) 78
9.2.3 Pacemaker Overall Volume (2000-2015) 80
9.3
Cardiac Rhythm Management Average Price (2000-2015) 82
9.4 Cardiac Rhythm
Management Distribution Share (2007-2008) 83
9.5 Cardiac Rhythm
Management, Netherlands, Company Share (2007-2008) 84
10 Cardiovascular
Monitoring and Diagnostic Devices In Netherlands 85
10.1 Cardiovascular
Monitoring and Diagnostic Devices Overall Revenue (2000-2015) 85
10.2
Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015)
87
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price
(2000-2015) 89
10.4 Cardiovascular Monitoring and Diagnostic Devices
Distribution Share (2007-2008) 90
10.5 Cardiovascular Monitoring and
Diagnostic Devices, Netherlands, Company Share (2007-2008) 91
11
Cardiovascular Prosthetic Devices In Netherlands 92
11.1 Cardiovascular
Prosthetic Devices Overall Revenue (2000-2015) 92
11.1.1 Cardiac Assist
Devices Overall Revenue (2000-2015) 94
11.1.2 Prosthetic Heart Valve
Overall Revenue (2000-2015) 96
11.2 Cardiovascular Prosthetic Devices
Overall Volume (2000-2015) 98
11.2.1 Cardiac Assist Devices Overall Volume
(2000-2015) 100
11.2.2 Prosthetic Heart Valve Overall Volume (2000-2015)
102
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015)
104
11.4 Cardiovascular Prosthetic Devices Distribution Share (2007-2008)
105
11.5 Cardiovascular Prosthetic Devices, Netherlands, Company Share
(2007-2008) 106
12 Cardiovascular Surgery In Netherlands 107
12.1
Cardiovascular Surgery Overall Revenue (2000-2015) 107
12.1.1 Perfusion
Disposables Overall Revenue (2000-2015) 109
12.2 Cardiovascular Surgery
Overall Volume (2000-2015) 111
12.2.1 Perfusion Disposables Overall Volume
(2000-2015) 112
12.3 Cardiovascular Surgery Average Price (2000-2015)
114
12.4 Cardiovascular Surgery Distribution Share (2007-2008) 115
12.5 Cardiovascular Surgery, Netherlands, Company Share (2007-2008) 116
13
Electrophysiology In Netherlands 117
13.1 Electrophysiology Overall
Revenue (2000-2015) 117
13.2 Electrophysiology Overall Volume (2000-2015)
119
13.3 Electrophysiology Average Price (2000-2015) 120
13.4
Electrophysiology Distribution Share (2007-2008) 121
13.5
Electrophysiology, Netherlands, Company Share (2007-2008) 122
14
Interventional Cardiology In Netherlands 123
14.1 Interventional
Cardiology Overall Revenue (2000-2015) 123
14.1.1 Cardiac Catheter Overall
Revenue (2000-2015) 127
14.1.2 Coronary Stent Overall Revenue (2000-2015)
129
14.1.3 PTCA Balloon Overall Revenue (2000-2015) 131
14.2
Interventional Cardiology Overall Volume (2000-2015) 133
14.2.1 Cardiac
Catheter Overall Volume (2000-2015) 135
14.2.2 Coronary Stent Overall
Volume (2000-2015) 137
14.2.3 PTCA Balloon Overall Volume (2000-2015)
139
14.3 Interventional Cardiology Average Price (2000-2015) 141
14.4
Interventional Cardiology Distribution Share (2007-2008) 143
14.5
Interventional Cardiology, Netherlands, Company Share (2007-2008) 144
15
Peripheral Vascular Devices In Netherlands 145
15.1 Peripheral Vascular
Devices Overall Revenue (2000-2015) 145
15.2 Peripheral Vascular Devices
Overall Volume (2000-2015) 149
15.3 Peripheral Vascular Devices Average
Price (2000-2015) 153
15.4 Peripheral Vascular Devices Distribution Share
(2007-2008) 154
15.5 Peripheral Vascular Devices, Netherlands, Company
Share (2007-2008) 155
16 Overview of Key Companies in Argentina
Cardiovascular Devices Market 156
16.1 Boston Scientific Corporation
156
16.1.1 Company Overview 156
16.1.2 Value Chain Analysis 157
16.1.2.1 Manufacturing 157
16.1.2.2 Product Development 158
16.1.2.3
Sales and Marketing 159
16.1.3 Boston Scientific Corporation Pipeline
Products 160
16.1.3.1 Boston Scientific Corporation Pipeline Products By
Equipment Type 160
16.1.3.2 Boston Scientific Corporation Pipeline
Products By Development Stage 161
16.1.3.3 Boston Scientific Corporation
Pipeline Products By Therapy Area 162
16.1.3.4 Boston Scientific
Corporation Pipeline Products By Clinical Trials 163
16.1.3.5 Boston
Scientific Corporation Pipeline Products By News Summary 164
16.2
Medtronic, Inc. 165
16.2.1 Company Overview 165
16.2.2 Value Chain
Analysis 165
16.2.2.1 Manufacturing 165
16.2.2.2 Product Development
166
16.2.2.3 Sales and Marketing 166
16.2.3 Medtronic, Inc. Pipeline
Products 168
16.2.3.1 Medtronic, Inc. Pipeline Products By Equipment Type
168
16.2.3.2 Medtronic, Inc. Pipeline Products By Development Stage
170
16.2.3.3 Medtronic, Inc. Pipeline Products By Therapy Area 172
16.2.3.4 Medtronic, Inc. Pipeline Products By Clinical Trials 174
16.2.3.5
Medtronic, Inc. Pipeline Products By News Summary 175
16.3 St. Jude
Medical, Inc. 177
16.3.1 Company Overview 177
16.3.2 Value Chain
Analysis 178
16.3.2.1 Manufacturing 178
16.3.2.2 Product Development
178
16.3.2.3 Sales and Marketing 179
16.3.3 St. Jude Medical Inc.
Pipeline Products 180
16.3.3.1 St. Jude Medical Inc. Pipeline Products By
Equipment Type 180
16.3.3.2 St. Jude Medical Inc. Pipeline Products By
Development Stage 182
16.3.3.3 St. Jude Medical Inc. Pipeline Products By
Therapy Area 183
16.3.3.4 St. Jude Medical Inc. Pipeline Products By
Clinical Trials 184
16.3.3.5 St. Jude Medical Inc. Pipeline Products By
News Summary 184
16.4 Cordis Corporation 185
16.4.1 Company Overview
185
16.4.2 Cordis Corporation Pipeline Products 185
16.4.2.1 Cordis
Corporation Pipeline Products By Equipment Type 185
16.4.2.2 Cordis
Corporation Pipeline Products By Development Stage 185
16.4.2.3 Cordis
Corporation Pipeline Products By Therapy Area 186
16.4.2.4 Cordis
Corporation Pipeline Products By Clinical Trials 186
16.4.2.5 Cordis
Corporation Pipeline Products By News Summary 186
16.5 BIOTRONIK GmbH &
Co. KG 187
16.5.1 Company Overview 187
16.5.2 BIOTRONIK GmbH & Co. KG
Pipeline Products 187
16.5.2.1 BIOTRONIK GmbH & Co. KG Pipeline Products
By Equipment Type 187
16.5.2.2 BIOTRONIK GmbH & Co. KG Pipeline Products
By Development Stage 187
16.5.2.3 BIOTRONIK GmbH & Co. KG Pipeline
Products By Therapy Area 188
16.5.2.4 BIOTRONIK GmbH & Co. KG Pipeline
Products By Clinical Trials 188
16.5.2.5 BIOTRONIK GmbH & Co. KG Pipeline
Products By News Summary 188
16.6 Abbott Laboratories 189
16.6.1
Company Overview 189
16.6.2 Value Chain Analysis 190
16.6.2.1
Manufacturing 190
16.6.2.2 Product Development 190
16.6.2.3 Sales and
Marketing 192
16.7 Sorin S.p.A. 193
16.7.1 Company Overview 193
16.7.2 Value Chain Analysis 194
16.7.2.1 Manufacturing 194
16.7.2.2
Product Development 194
16.7.2.3 Sales and Marketing 196
16.7.3 Sorin
Group Pipeline Products 197
16.7.3.1 Sorin Group Pipeline Products By
Equipment Type 197
16.7.3.2 Sorin Group Pipeline Products By Development
Stage 197
16.7.3.3 Sorin Group Pipeline Products By Therapy Area 198
16.7.3.4 Sorin Group Pipeline Products By Clinical Trials 198
16.7.3.5
Sorin Group Pipeline Products By News Summary 198
16.8 GE Healthcare
199
16.8.1 Company Overview 199
16.8.2 GE Healthcare Pipeline Products
199
16.8.2.1 GE Healthcare Pipeline Products By Equipment Type 199
16.8.2.2 GE Healthcare Pipeline Products By Development Stage 199
16.8.2.3
GE Healthcare Pipeline Products By Therapy Area 200
16.8.2.4 GE Healthcare
Pipeline Products By Clinical Trials 200
16.8.2.5 GE Healthcare Pipeline
Products By News Summary 200
16.9 Philips Healthcare 201
16.9.1
Company Overview 201
16.9.2 Value Chain Analysis 202
16.9.2.1
Manufacturing 202
16.9.2.2 Product Development 203
16.9.2.3 Sales and
Marketing 204
16.10 Cardiac Science Corporation 205
16.10.1 Company
Overview 205
16.10.2 Value Chain Analysis 206
16.10.2.1 Manufacturing
206
16.10.2.2 Product Development 207
16.10.2.3 Sales and Marketing
207
16.11 Nihon Kohden Corporation 209
16.11.1 Company Overview
209
16.11.2 Value Chain Analysis 210
16.11.2.1 Manufacturing 210
16.11.2.2 Product Development 210
16.11.2.3 Sales and Marketing 211
16.12 Edwards Lifesciences Corporation 212
16.12.1 Company Overview
212
16.12.2 Value Chain Analysis 212
16.12.2.1 Manufacturing 213
16.12.2.2 Product Development 213
16.12.2.3 Sales and Marketing 214
16.12.3 Edwards Lifesciences Corporation Pipeline Products 214
16.12.3.1
Edwards Lifesciences Corporation Pipeline Products By Equipment Type 214
16.12.3.2 Edwards Lifesciences Corporation Pipeline Products By Development
Stage 215
16.12.3.3 Edwards Lifesciences Corporation Pipeline Products By
Therapy Area 215
16.12.3.4 Edwards Lifesciences Corporation Pipeline
Products By Clinical Trials 216
16.12.3.5 Edwards Lifesciences Corporation
Pipeline Products By News Summary 216
16.13 MAQUET GmbH & Co. KG 217
16.13.1 Company Overview 217
16.14 Terumo Corporation 218
16.14.1
Company Overview 218
16.14.2 Value Chain Analysis 218
16.14.2.1
Manufacturing 219
16.14.2.2 Product Development 219
16.14.2.3 Sales
and Marketing 220
16.14.3 Terumo Corporation Pipeline Products 220
16.14.3.1 Terumo Corporation Pipeline Products By Equipment Type 220
16.14.3.2 Terumo Corporation Pipeline Products By Development Stage 220
16.14.3.3 Terumo Corporation Pipeline Products By Therapy Area 221
16.14.3.4 Terumo Corporation Pipeline Products By Clinical Trials 221
16.14.3.5 Terumo Corporation Pipeline Products By News Summary 221
16.15
AtriCure, Inc. 223
16.15.1 Company Overview 223
16.15.1.1 AtriCure,
Inc. Pipeline Products 223
16.15.1.2 AtriCure, Inc. Pipeline Products By
Equipment Type 223
16.15.1.3 AtriCure, Inc. Pipeline Products By
Development Stage 223
16.15.1.4 AtriCure, Inc. Pipeline Products By
Therapy Area 224
16.15.1.5 AtriCure, Inc. Pipeline Products By Clinical
Trials 224
16.15.1.6 AtriCure, Inc. Pipeline Products By News Summary
224
16.16 ev3 Inc. 225
16.16.1 Company Overview 225
16.16.2 Value
Chain Analysis 226
16.16.2.1 Manufacturing 226
16.16.2.2 Product
Development 227
16.16.2.3 Sales and Marketing 227
16.16.3 ev3 Inc.
Pipeline Products 228
16.16.3.1 ev3 Inc. Pipeline ProductsBy Equipment
Type 228
16.16.3.2 ev3 Inc. Pipeline Products By Development Stage 228
16.16.3.3 ev3 Inc. Pipeline Products By Therapy Area 229
16.16.3.4 ev3
Inc. Pipeline Products By Clinical Trials 229
16.16.3.5 ev3 Inc. Pipeline
Products By News Summary 229
16.17 OSI Systems, Inc. 230
16.17.1
Company Overview 230
16.17.2 Value Chain Analysis 231
16.17.2.1
Manufacturing 231
16.17.2.2 Product Development 232
16.17.2.3 Sales
and Marketing 232
16.18 Datascope Corporation 233
16.18.1 Company
Overview 233
16.18.2 Value Chain Analysis 233
16.18.2.1 Manufacturing
234
16.18.2.2 Product Development 234
16.18.2.3 Sales and Marketing
235
16.19 ABIOMED, Inc. 236
16.19.1 Company Overview 236
16.19.2
Value Chain Analysis 236
16.19.2.1 Manufacturing 237
16.19.2.2 Product
Development 237
16.19.2.3 Sales and Marketing 238
16.19.3 ABIOMED,
Inc. Pipeline Products 238
16.19.3.1 ABIOMED, Inc. Pipeline Products By
Equipment Type 238
16.19.3.2 ABIOMED, Inc. Pipeline Products By
Development Stage 238
16.19.3.3 ABIOMED, Inc. Pipeline Products By Therapy
Area 239
16.19.3.4 ABIOMED, Inc. Pipeline Products By Clinical Trials
239
16.19.3.5 ABIOMED, Inc. Pipeline Products By News Summary 239
16.20 Thoratec Corporation 240
16.20.1 Company Overview 240
16.20.2
Value Chain Analysis 241
16.20.2.1 Manufacturing 241
16.20.2.2 Product
Development 242
16.20.2.3 Sales and Marketing 242
16.20.2.4 Thoratec
Corporation Pipeline Products 243
16.20.2.5 Thoratec Corporation Pipeline
Products By Equipment Type 243
16.20.2.6 Thoratec Corporation Pipeline
Products By Development Stage 243
16.20.2.7 Thoratec Corporation Pipeline
Products By Therapy Area 243
16.20.2.8 Thoratec Corporation Pipeline
Products By Clinical Trials 244
16.20.2.9 Thoratec Corporation Pipeline
Products By News Summary 244
16.21 C.R. Bard, Inc. 245
16.21.1 Company
Overview 245
16.21.2 Value Chain Analysis 245
16.21.2.1 Manufacturing
246
16.21.2.2 Product Development 246
16.21.2.3 Sales and Marketing
247
16.21.3 C.R. Bard, Inc. Pipeline Products 247
16.21.3.1 C.R. Bard,
Inc. Pipeline Products By Equipment Type 247
16.21.3.2 C.R. Bard, Inc.
Pipeline Products By Development Stage 248
16.21.3.3 C.R. Bard, Inc.
Pipeline Products By Therapy Area 248
16.21.3.4 C.R. Bard, Inc. Pipeline
Products By Clinical Trials 249
16.22 Arrow International, Inc. 250
16.22.1 Company Overview 250
16.22.2 Value Chain Analysis 251
16.22.2.1 Manufacturing 252
16.22.2.2 Product Development 252
16.22.2.3 Sales and Marketing 253
16.22.3 Arrow International, Inc.
Pipeline Products 253
16.22.3.1 Arrow International, Inc. Pipeline
Products By Equipment Type 253
16.22.4 Arrow International, Inc. Pipeline
Products By Development Stage 253
16.22.4.1 Arrow International, Inc.
Pipeline Products By Therapy Area 254
16.22.4.2 Arrow International, Inc.
Pipeline Products By Clinical Trials 254
16.23 Invatec S.r.l. 255
16.23.1 Company Overview 255
16.23.2 Invatec S.r.l. Pipeline Products
255
16.23.2.1 Invatec S.r.l. Pipeline Products By Equipment Type 255
16.23.2.2 Invatec S.r.l. Pipeline Products By Development Stage 256
16.23.2.3 Invatec S.r.l. Pipeline Products By Therapy Area 257
16.23.2.4
Invatec S.r.l. Pipeline Products By Clinical Trials 258
16.23.2.5 Invatec
S.r.l. Pipeline Products By News Summary 258
16.24 Fukuda Denshi Co., Ltd.
259
16.24.1 Company Overview 259
16.25 Welch Allyn Inc. 259
16.25.1 Company Overview 259
16.26 BMEYE B.V. 260
16.26.1 Company
Overview 260
16.27 CardioTek B.V. 260
16.27.1 Company Overview 260
17 Financial Deals Landscape 261
17.1 Merger 261
17.1.1 Wyeth
Withdraws Merger Discussions With Crucell 261
18 Recent Developments
262
18.1 Product News 262
18.1.1 Feb 12, 2009: MitraClip System Of
Evalve Treats First Series Of Dutch Patients 262
18.1.2 Jan 15, 2009:
vProtect Luminal Shield Successfully Stabilizes Vulnerable Plaque 262
18.2
Product News 263
18.2.1 Feb 12, 2009: MitraClip System Of Evalve Treats
First Series Of Dutch Patients 263
18.2.2 Jan 15, 2009: vProtect Luminal
Shield Successfully Stabilizes Vulnerable Plaque 263
19 Appendix 264
19.1 Global Markets Direct Research Methodology 264
19.2 Coverage 265
19.3 Secondary Research 265
19.4 Primary Research 266
19.5 Models
266
19.6 Forecasts 267
19.7 Expert Panel Validation 267
19.8
Currency Conversion 268
19.9 Contact Us 269
19.10 Disclaimer 269
1.1 List of Tables
Table 1: Doctors by Specialty in
Netherlands, 2000-2006 35
Table 2: Hospital Wards by Type in Netherlands,
2000-2006 36
Table 4: Cardiovascular Devices, Netherlands, Overall
Revenue ($ mn), 2000-2015 54
Table 5: Cardiovascular Devices, Netherlands,
Cross-Category Analysis, 2000-2015 55
Table 6: Cardiovascular
Devices, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008 57
Table
7: Cardiovascular Devices, Netherlands, Overall Revenue ($ mn), Forecast,
2008-2015 59
Table 8: Cardiovascular Devices, Netherlands, Category
Volume (Units), 2000-2015 60
Table 9: Cardiovascular Devices,
Netherlands, Category Volume (Units), Historic, 2000-2008 62
Table 10:
Cardiovascular Devices, Netherlands, Category Volume (Units), Forecast,
2008-2015 64
Table 11: Cardiovascular Devices, Netherlands, Company
Share by Revenue ($ mn), 2007-2008 65
Table 12: Cardiac Rhythm
Management, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008 66
Table 13: Cardiac Rhythm Management, Netherlands, Revenue ($ mn) by
Segment, Forecast, 2008-2015 67
Table 14: Cardiac Resynchronisation
Therapy, Netherlands, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
68
Table 15: Cardiac Resynchronisation Therapy, Netherlands, Revenue
($ mn) by Sub-Segment, Forecast, 2008-2015 69
Table 16: Implantable
Cardioverter Defibrillator, Netherlands, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 70
Table 17: Implantable Cardioverter
Defibrillator, Netherlands, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
71
Table 18: Pacemaker, Netherlands, Revenue ($ mn) by Sub-Segment,
Historic, 2000-2008 72
Table 19: Pacemaker, Netherlands, Revenue ($
mn) by Sub-Segment, Forecast, 2008-2015 73
Table 20: Cardiac Rhythm
Management, Netherlands, Volume (Units) by Segment, Historic, 2000-2008 74
Table 21: Cardiac Rhythm Management, Netherlands, Volume (Units) by
Segment, Forecast, 2008-2015 75
Table 22: Cardiac Resynchronisation
Therapy, Netherlands, Volume (Units) by Sub-Segment, Historic, 2000-2008
76
Table 23: Cardiac Resynchronisation Therapy, Netherlands, Volume
(Units) by Sub-Segment, Forecast, 2008-2015 77
Table 24: Implantable
Cardioverter Defibrillator, Netherlands, Volume (Units) by Sub-Segment,
Historic, 2000-2008 78
Table 25: Implantable Cardioverter
Defibrillator, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2008-2015
79
Table 26: Pacemaker, Netherlands, Volume (Units) by Sub-Segment,
Historic, 2000-2008 80
Table 27: Pacemaker, Netherlands, Volume
(Units) by Sub-Segment, Forecast, 2008-2015 81
Table 28: Cardiac
Rhythm Management, Netherlands, Average Price ($), Historic, 2000-2008 82
Table 29: Cardiac Rhythm Management, Netherlands, Average Price ($),
Forecast, 2008-2015 82
Table 30: Cardiac Rhythm Management,
Netherlands, Distribution Share by Revenue ($mn), 2007-2008 83
Table 31:
Cardiac Rhythm Management, Netherlands, Company Share by Revenue ($ mn),
2007-2008 84
Table 32: Cardiovascular Monitoring and Diagnostic
Devices, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008 85
Table 33: Cardiovascular Monitoring and Diagnostic Devices, Netherlands,
Revenue ($ mn) by Segment, Forecast, 2008-2015 86
Table 34:
Cardiovascular Monitoring and Diagnostic Devices, Netherlands, Volume (Units)
by Segment, Historic, 2000-2008 87
Table 35: Cardiovascular
Monitoring and Diagnostic Devices, Netherlands, Volume (Units) by Segment,
Forecast, 2008-2015 88
Table 36: Cardiovascular Monitoring and
Diagnostic Devices, Netherlands, Average Price ($), Historic, 2000-2008 89
Table 37: Cardiovascular Monitoring and Diagnostic Devices, Netherlands,
Average Price ($), Forecast, 2008-2015 89
Table 38: Cardiovascular
Monitoring and Diagnostic Devices, Netherlands, Distribution Share by Revenue
($mn), 2007-2008 90
Table 39: Cardiovascular Monitoring and
Diagnostic Devices, Netherlands, Company Share by Revenue ($ mn), 2007-2008
91
Table 40: Cardiovascular Prosthetic Devices, Netherlands, Revenue
($ mn) by Segment, Historic, 2000-2008 92
Table 41: Cardiovascular
Prosthetic Devices, Netherlands, Revenue ($ mn) by Segment, Forecast,
2008-2015 93
Table 42: Cardiac Assist Devices, Netherlands, Revenue
($ mn) by Sub-Segment, Historic, 2000-2008 94
Table 43: Cardiac
Assist Devices, Netherlands, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 95
Table 44: Prosthetic Heart Valve, Netherlands, Revenue
($ mn) by Sub-Segment, Historic, 2000-2008 96
Table 45: Prosthetic
Heart Valve, Netherlands, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
97
Table 46: Cardiovascular Prosthetic Devices, Netherlands, Volume
(Units) by Segment, Historic, 2000-2008 98
Table 47: Cardiovascular
Prosthetic Devices, Netherlands, Volume (Units) by Segment, Forecast,
2008-2015 99
Table 48: Cardiac Assist Devices, Netherlands, Volume
(Units) by Sub-Segment, Historic, 2000-2008 100
Table 49: Cardiac
Assist Devices, Netherlands, Volume (Units) by Sub-Segment, Forecast,
2008-2015 101
Table 50: Prosthetic Heart Valve, Netherlands, Volume
(Units) by Sub-Segment, Historic, 2000-2008 102
Table 51: Prosthetic
Heart Valve, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2008-2015
103
Table 52: Cardiovascular Prosthetic Devices, Netherlands, Average
Price ($), Historic, 2000-2008 104
Table 53: Cardiovascular
Prosthetic Devices, Netherlands, Average Price ($), Forecast, 2008-2015
104
Table 54: Cardiovascular Prosthetic Devices, Netherlands,
Distribution Share by Revenue ($mn), 2007-2008 105
Table 55:
Cardiovascular Prosthetic Devices, Netherlands, Company Share by Revenue ($
mn), 2007-2008 106
Table 56: Cardiovascular Surgery, Netherlands,
Revenue ($ mn) by Segment, Historic, 2000-2008 107
Table 57:
Cardiovascular Surgery, Netherlands, Revenue ($ mn) by Segment, Forecast,
2008-2015 108
Table 58: Perfusion Disposables, Netherlands, Revenue
($ mn) by Sub-Segment, Historic, 2000-2008 109
Table 59: Perfusion
Disposables, Netherlands, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
110
Table 60: Cardiovascular Surgery, Netherlands, Volume (Units) by
Segment, Historic, 2000-2008 111
Table 61: Cardiovascular Surgery,
Netherlands, Volume (Units) by Segment, Forecast, 2008-2015 111
Table 62:
Perfusion Disposables, Netherlands, Volume (Units) by Sub-Segment,
Historic, 2000-2008 112
Table 63: Perfusion Disposables, Netherlands,
Volume (Units) by Sub-Segment, Forecast, 2008-2015 113
Table 64:
Cardiovascular Surgery, Netherlands, Average Price ($), Historic, 2000-2008
114
Table 65: Cardiovascular Surgery, Netherlands, Average Price ($),
Forecast, 2008-2015 114
Table 66: Cardiovascular Surgery,
Netherlands, Distribution Share by Revenue ($mn), 2007-2008 115
Table 67:
Cardiovascular Surgery, Netherlands, Company Share by Revenue ($ mn),
2007-2008 116
Table 68: Electrophysiology, Netherlands, Revenue ($
mn) by Segment, Historic, 2000-2008 117
Table 69: Electrophysiology,
Netherlands, Revenue ($ mn) by Segment, Forecast, 2008-2015 118
Table 70:
Electrophysiology, Netherlands, Volume (Units) by Segment, Historic,
2000-2008 119
Table 71: Electrophysiology, Netherlands, Volume
(Units) by Segment, Forecast, 2008-2015 119
Table 72:
Electrophysiology, Netherlands, Average Price ($), Historic, 2000-2008 120
Table 73: Electrophysiology, Netherlands, Average Price ($), Forecast,
2008-2015 120
Table 74: Electrophysiology, Netherlands, Distribution
Share by Revenue ($mn), 2007-2008 121
Table 75: Electrophysiology,
Netherlands, Company Share by Revenue ($ mn), 2007-2008 122
Table 76:
Interventional Cardiology, Netherlands, Revenue ($ mn) by Segment, Historic,
2000-2008 124
Table 77: Interventional Cardiology, Netherlands,
Revenue ($ mn) by Segment, Forecast, 2008-2015 126
Table 78: Cardiac
Catheter, Netherlands, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
127
Table 79: Cardiac Catheter, Netherlands, Revenue ($ mn) by
Sub-Segment, Forecast, 2008-2015 128
Table 80: Coronary Stent,
Netherlands, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 129
Table
81: Coronary Stent, Netherlands, Revenue ($ mn) by Sub-Segment, Forecast,
2008-2015 130
Table 82: PTCA Balloon, Netherlands, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 131
Table 83: PTCA Balloon,
Netherlands, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 132
Table
84: Interventional Cardiology, Netherlands, Volume (Units) by Segment,
Historic, 2000-2008 133
Table 85: Interventional Cardiology,
Netherlands, Volume (Units) by Segment, Forecast, 2008-2015 134
Table 86:
Cardiac Catheter, Netherlands, Volume (Units) by Sub-Segment, Historic,
2000-2008 135
Table 87: Cardiac Catheter, Netherlands, Volume (Units)
by Sub-Segment, Forecast, 2008-2015 136
Table 88: Coronary Stent,
Netherlands, Volume (Units) by Sub-Segment, Historic, 2000-2008 137
Table
89: Coronary Stent, Netherlands, Volume (Units) by Sub-Segment, Forecast,
2008-2015 138
Table 90: PTCA Balloon, Netherlands, Volume (Units) by
Sub-Segment, Historic, 2000-2008 139
Table 91: PTCA Balloon,
Netherlands, Volume (Units) by Sub-Segment, Forecast, 2008-2015 140
Table
92: Interventional Cardiology, Netherlands, Average Price ($), Historic,
2000-2008 141
Table 93: Interventional Cardiology, Netherlands,
Average Price ($), Forecast, 2008-2015 142
Table 94: Interventional
Cardiology, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
143
Table 95: Interventional Cardiology, Netherlands, Company Share
by Revenue ($ mn), 2007-2008 144
Table 96: Peripheral Vascular
Devices, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008 146
Table 97: Peripheral Vascular Devices, Netherlands, Revenue ($ mn) by
Segment, Forecast, 2008-2015 148
Table 98: Peripheral Vascular
Devices, Netherlands, Volume (Units) by Segment, Historic, 2000-2008 150
Table 99: Peripheral Vascular Devices, Netherlands, Volume (Units) by
Segment, Forecast, 2008-2015 152
Table 100: Peripheral Vascular
Devices, Netherlands, Average Price ($), Historic, 2000-2008 153
Table
101: Peripheral Vascular Devices, Netherlands, Average Price ($),
Forecast, 2008-2015 153
Table 102: Peripheral Vascular Devices,
Netherlands, Distribution Share by Revenue ($mn), 2007-2008 154
Table 103:
Peripheral Vascular Devices, Netherlands, Company Share by Revenue ($
mn), 2007-2008 155
Table 104: Boston Scientific Corporation Pipeline
Products by Equipment Type 160
Table 105: Boston Scientific
Corporation Pipeline Products By Development Stage 161
Table 106:
Boston Scientific Corporation Pipeline Products By Therapy Area 162
Table
107: Boston Scientific Corporation Pipeline Products By Clinical Trials
163
Table 108: Boston Scientific Corporation Pipeline Products By
News Summary 164
Table 109: Medtronic, Inc. Pipeline Products by
Equipment Type 168
Table 110: Medtronic, Inc. Pipeline Products By
Development Stage 170
Table 111: Medtronic, Inc. Pipeline Products By
Therapy Area 172
Table 112: Medtronic, Inc. Pipeline Products By
Clinical Trials 174
Table 113: Medtronic, Inc. Pipeline Products By
News Summary 175
Table 114: St. Jude Medical Inc. Pipeline Products
by Equipment Type 180
Table 115: St. Jude Medical Inc. Pipeline
Products By Development Stage 182
Table 116: St. Jude Medical Inc.
Pipeline Products By Therapy Area 183
Table 117: St. Jude Medical
Inc. Pipeline Products By Clinical Trials 184
Table 118: St. Jude
Medical Inc. Pipeline Products By News Summary 184
Table 119: Cordis
Corporation Pipeline Products by Equipment Type 185
Table 120: Cordis
Corporation Pipeline Products By Development Stage 185
Table 121:
Cordis Corporation Pipeline Products By Therapy Area 186
Table 122:
Cordis Corporation Pipeline Products By Clinical Trials 186
Table 123:
Cordis Corporation Pipeline Products By News Summary 186
Table 124:
BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type 187
Table 125:
BIOTRONIK GmbH & Co. KG Pipeline Products By Development Stage 187
Table 126: BIOTRONIK GmbH & Co. KG Pipeline Products By Therapy Area
188
Table 127: BIOTRONIK GmbH & Co. KG Pipeline Products By Clinical
Trials 188
Table 128: BIOTRONIK GmbH & Co. KG Pipeline Products By
News Summary 188
Table 129: Sorin Group Pipeline Products by
Equipment Type 197
Table 130: Sorin Group Pipeline Products By
Development Stage 197
Table 131: Sorin Group Pipeline Products By
Therapy Area 198
Table 132: Sorin Group Pipeline Products By Clinical
Trials 198
Table 133: Sorin Group Pipeline Products By News Summary
198
Table 134: GE Healthcare Pipeline Products by Equipment Type
199
Table 135: GE Healthcare Pipeline Products By Development Stage
199
Table 136: GE Healthcare Pipeline Products By Therapy Area
200
Table 137: GE Healthcare Pipeline Products By Clinical Trials
200
Table 138: GE Healthcare Pipeline Products By News Summary
200
Table 139: Edwards Lifesciences Corporation Pipeline Products by
Equipment Type 214
Table 140: Edwards Lifesciences Corporation
Pipeline Products By Development Stage 215
Table 141: Edwards
Lifesciences Corporation Pipeline Products By Therapy Area 215
Table 142:
Edwards Lifesciences Corporation Pipeline Products By Clinical Trials
216
Table 143: Edwards Lifesciences Corporation Pipeline Products By
News Summary 216
Table 144: Terumo Corporation Pipeline Products by
Equipment Type 220
Table 145: Terumo Corporation Pipeline Products By
Development Stage 220
Table 146: Terumo Corporation Pipeline Products
By Therapy Area 221
Table 147: Terumo Corporation Pipeline Products
By Clinical Trials 221
Table 148: Terumo Corporation Pipeline
Products By News Summary 221
Table 149: AtriCure, Inc. Pipeline
Products by Equipment Type 223
Table 150: AtriCure, Inc. Pipeline
Products By Development Stage 223
Table 151: AtriCure, Inc. Pipeline
Products By Therapy Area 224
Table 152: AtriCure, Inc. Pipeline
Products By Clinical Trials 224
Table 153: AtriCure, Inc. Pipeline
Products By News Summary 224
Table 154: ev3 Inc. Pipeline Products by
Equipment Type 228
Table 155: ev3 Inc. Pipeline Products By
Development Stage 228
Table 156: ev3 Inc. Pipeline Products By
Therapy Area 229
Table 157: ev3 Inc. Pipeline Products By Clinical
Trials 229
Table 158: ev3 Inc. Pipeline Products By News Summary
229
Table 159: ABIOMED, Inc. Pipeline Products by Equipment Type
238
Table 160: ABIOMED, Inc. Pipeline Products By Development Stage
238
Table 161: ABIOMED, Inc. Pipeline Produ
|
Related Report
|
View Cart
